Verisma secures Golub Capital debt to fund M&A and tech push

What's the deal? Verisma, a health information lifecycle management (HILM) company, has closed new senior-secured financing from Golub CapitalDealroom has a profile for this one. Try Dealroom →. The debt package includes a delayed-draw term loan facility and will fund technology investment and acquisitions. Verisma did not disclose the amount or terms.

What does Verisma do? It helps healthcare organisations manage, exchange, and protect health data, serving more than 20,000 clients across 50 states. Its product suite spans archiving, care coordination, release of information, and value-based care. The company is backed by private equity firm NewSpring CapitalDealroom has a profile for this one. Try Dealroom →.

What's the endgame? Chief executive officer Marty McKenna said the financing gives Verisma "the firepower to accelerate our growth, through both organic development and M&A." The company is positioning itself to expand as what McKenna called "the premier HILM vendor."

Why now? Verisma spent 2026 pushing new tools, including Inbound Document Intelligence for quality reporting and Archiving Chart Search for locating data across archived records. It was also named top vendor for release of information and HILM for the eighth consecutive year by Black Book Research. The new capacity sharpens the question of whether product investment can turn into durable growth.

The lender's view: Golub Capital, which had over $95 billion of capital under management as of October 1, 2026, framed the deal around Verisma's market position. "We are pleased to partner with Verisma and NewSpring Capital to support the company's long-term growth objectives," said Spyro Alexopoulos, co-president and co-head of sponsor finance.

The signal: The financing reflects a broader pattern of private capital backing healthcare data businesses. In February, Main Street CapitalDealroom has a profile for this one. Try Dealroom → helped finance a leveraged buyout of a healthcare data-services provider; in June, Abry PartnersDealroom has a profile for this one. Try Dealroom →' $780 million Centauri continuation vehicle included fresh capital for growth and acquisitions. For Verisma, the deal matters less as a disclosed milestone than as added firepower in a field where providers face rising demands to manage and protect health information.

Read more: markets.financialcontent.com

Image credit: Generated with Gemini